-
Information-Publications
-
TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIsDetails
-
Pterostilbene interferes with lipopolysaccharide-induced myocardial injury through oxidative stress and inflammasome pathwaysDetails
-
Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complexDetails
-
Resveratrol Inhibits Zinc Deficiency-Induced Mitophagy and Exerts Cardioprotective EffectsDetails
-
The FOXM1/RNF26/p57 axis regulates the cell cycle to promote the aggressiveness of bladder cancerDetails
-
Effects and Action Mechanism of Huoxue Tongluo Formula on the Formation of Neutrophil Extracellular TrapsDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands